<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1575">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02026700</url>
  </required_header>
  <id_info>
    <org_study_id>bariederm-HMO-CTIL</org_study_id>
    <nct_id>NCT02026700</nct_id>
  </id_info>
  <brief_title>Bariederm Cream in Chronic Contact Dermatitis</brief_title>
  <official_title>Bariederm Cream in Chronic Contact Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We intend to evaluate the efficiency and tolerability of a barrier cream (bariederm) in
      protecting hands of individuals with hand dermatitis, either due to allergy or irritation.
      We believe that the use of the cream would benefit with the skin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is the evaluation of the effectiveness, tolerance and cosmetic
      acceptability of Bariéderm cream among patients presenting with chronic allergic or irritant
      contact dermatitis of the hands. We shall enrol adults presenting with CONTACT DERMATITIS
      EXCLUDING FLARE-UPS of the hands: whether allergic or irritant, able to understand the
      protocol and agrees to sign the information and informed consent form. Bariéderm cream will
      be applied minimum twice daily over 21 days. Response will be evaluated by self and
      physician filled questionnaires. effectiveness, tolerance and cosmetic acceptability will be
      evaluated by a scale of 1-10, 1 meaning &quot;not at all&quot; and 10 meaning &quot;very much&quot;. Statistics
      will be performed by SPSS software with suitable statistical tests. In case of an adverse
      event caused by the product, patch-test with ingredients of Bariéderm cream will be
      performed.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>self evaluation of effectiveness and tolerance in a 1-10 scale</measure>
    <time_frame>21 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>effectiveness tolerance and acceptability in adults with hand dermatitis, evaluated by a self reported and a physician reported questionaires, using a 1-10 scale for evaluation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Contact Dermatitis</condition>
  <arm_group>
    <arm_group_label>bariederm, barrier cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one arm study: use of bariederm cream on hands twice daily for 21 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bariederm cream</intervention_name>
    <description>patients are asked to apply twice a day a barrier cream on their hands for 3 weeks only</description>
    <arm_group_label>bariederm, barrier cream</arm_group_label>
    <other_name>use of bariederm cream on hands twice daily for 21 days</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with dermatitis of the hands

        Exclusion Criteria:

          -  pregnant ladies,

          -  known allergy to ingredients  -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liran Horev Yakir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Dermatology, Hadassah Medical Center, Jerusalem 911201, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>liran horev, md</last_name>
    <phone>00972508573992</phone>
    <email>rlirano@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>: Hadassah Medical Organization, Jerusalem, Israel</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 2, 2014</lastchanged_date>
  <firstreceived_date>December 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>rliranoHMO</investigator_full_name>
    <investigator_title>DR</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
